Led Bioscan Research's $1M seed round.
Bioscan Research is dedicated to advancing the science of early brain injury detection, focusing on developing innovative, non-invasive technologies for timely identification and triage of traumatic brain injury (TBI)
Bioscan Research is dedicated to advancing the science of early brain injury detection, focusing on developing innovative, non-invasive technologies for timely identification and triage of traumatic brain injury (TBI). Their flagship device, CEREBO®, uses near-infrared spectroscopy and adaptive machine learning to assist clinicians in detecting intracranial hemorrhage at the point of care.